EUVIMEDEUVIMED entdecken
Open Access

Contemporary Use of Balloon Aortic Valvuloplasty in the Era of Transcatheter Aortic Valve Implantation

Dawn S Hui, David M Shavelle, Mark J Cunningham, Ray V Matthews, Vaughn A Starnes

Texas Heart Institute Journal · 2014-10 · 41 (5) · 469-476

DOI: 10.14503/thij-13-3757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Texas Heart Institute Journal, 2014-10. Verfasst von Dawn S Hui und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Balloon Valvuloplasty, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of transcatheter aortic valve implantation (TAVI) has increased the use of balloon aortic valvuloplasty (BAV) in treating aortic stenosis. We evaluated our use of BAV in an academic tertiary referral center with a developing TAVI program. We reviewed 69 consecutive stand-alone BAV procedures that were performed in 62 patients (mean age, 77 ± 10 yr; 62% men; baseline mean New York Heart Association functional class, 3 ± 1) from January 2009 through December 2012. Enrollment for the CoreValve ® clinical trial began in January 2011. We divided the study cohort into 2 distinct periods, defined as pre-TAVI (2009–2010) and TAVI (2011–2012). We reviewed clinical, hemodynamic, and follow-up data, calculating each BAV procedure as a separate case. Stand-alone BAV use increased 145% from the pre-TAVI period to the TAVI period. The mean aortic gradient reduction was 13 ± 10 mmHg. Patients were successfully bridged as intended to cardiac or noncardiac surgery in 100% of instances and to TAVI in 60%. Five patients stabilized with BAV subsequently underwent surgical aortic valve replacement with no operative deaths. The overall in-hospital mortality rate (17.4%) was highest in emergent patients (61%). The implementation of a TAVI program was associated with a significant change in BAV volumes and indications. Balloon aortic valvuloplasty can successfully bridge patients to surgery or TAVI, although least successfully in patients nearer death. As TAVI expands to more centers and higher-risk patient groups, BAV might become integral to collaborative treatment decisions by surgeons and interventional cardiologists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Balloon ValvuloplastyTranscatheter Aortic Valve ReplacementAdultAgedAged, 80 and overAortic Valve StenosisFemaleHospital MortalityHumansMaleMiddle AgedPatient SelectionRetrospective StudiesTertiary Care CentersTreatment Outcome

Stichwörter der Autor:innen

Aortic valve stenosis/therapyballoon valvuloplasty/adverse effects/methods/mortalitydisease managementheart valve prosthesis implantation/methodspatient selectionrisk assessment/methodstreatment outcome

Zitieren

APA

Hui, D. S., Shavelle, D. M., Cunningham, M. J., Matthews, R. V., & Starnes, V. A. (2014). Contemporary Use of Balloon Aortic Valvuloplasty in the Era of Transcatheter Aortic Valve Implantation. Texas Heart Institute Journal, 41(5), 469-476. https://doi.org/10.14503/thij-13-3757

Vancouver

Hui DS, Shavelle DM, Cunningham MJ, Matthews RV, Starnes VA. Contemporary Use of Balloon Aortic Valvuloplasty in the Era of Transcatheter Aortic Valve Implantation. Texas Heart Institute Journal. 2014;41(5):469-476. doi:10.14503/thij-13-3757

BibTeX
@article{Hui2014,
  author = {Hui, Dawn S and Shavelle, David M and Cunningham, Mark J and Matthews, Ray V and Starnes, Vaughn A},
  title = {Contemporary Use of Balloon Aortic Valvuloplasty in the Era of Transcatheter Aortic Valve Implantation},
  journal = {Texas Heart Institute Journal},
  year = {2014},
  volume = {41},
  number = {5},
  pages = {469--476},
  doi = {10.14503/thij-13-3757}
}
Kostenlos starten →